Pharmacologic considerations for cataract surgery.
OBJECTIVE
A variety of options exist for perioperative, intraoperative, and postoperative medications in cataract surgery. This article reviews some of the more timely literature on "controversial" subjects in this area.


RESULTS
Recent literature may support the rationale for intracameral vancomycin at the time of cataract surgery. The recently released fluoroquinolones moxifloxacin and gatifloxacin are reviewed in terms of their clinical properties. Pharmacologic adjuncts to surgery are discussed, as is the use of intravitreal triamcinolone both at the time of cataract surgery and postoperatively.


CONCLUSIONS
Recent advances in ophthalmic pharmacology should aid the practicing anterior segment surgeon. This may affect preoperative, postoperative, and even intraoperative regimens.
Tipperman
Richard
R
Wills Eye Hospital, Philadelphia, Pennsylvania 19106, USA. rtipperman@mindspring.com
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001372:Aza Compounds / Q000494:pharmacology / Q000627:therapeutic use; D002387:Cataract Extraction; D024841:Fluoroquinolones / Q000494:pharmacology / Q000627:therapeutic use; D000077734:Gatifloxacin; D006801:Humans; D000077266:Moxifloxacin; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D014222:Triamcinolone Acetonide / Q000494:pharmacology / Q000627:therapeutic use; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D009883:Ophthalmic Solutions; D011804:Quinolines; D014640:Vancomycin; D014222:Triamcinolone Acetonide; D000077734:Gatifloxacin; D000077266:Moxifloxacin